Shareholders to Vote on Redomiciling to Nevada, Restructuring Capital
JUSHF sits 96% above its 52-week low of $0.265 on light trading volume (0.4× avg).
Summary
Jushi Holdings Inc. filed a definitive proxy statement for a shareholder meeting on June 24, 2026, to vote on redomiciling to Nevada, USA, and restructuring its authorized capital, a move aimed at improving US capital market access.
Key Events · Corporate Governance and Compliance · JUSHF
-
Proposed Redomiciliation to Nevada
Shareholders will vote on a special resolution to change the company's legal domicile from British Columbia, Canada, to Nevada, USA, to better align with its US-centric operations and strategic objectives.
-
Shareholder Meeting Scheduled
The annual general and special meeting of shareholders is set for June 24, 2026, where the redomiciliation and other governance matters will be considered.
-
Capital Structure Restructuring
The authorized capital will be amended to consist of 2 billion shares of Nevada Common Stock and 1 billion shares of undesignated Nevada Preferred Stock, replacing the current unlimited share structure. Existing shares, options, and warrants will convert 1:1 without dilution.
-
Strategic Benefits Highlighted
The company anticipates enhanced acceptance in US capital markets, improved stock marketability, and potential for easier listing on a major US exchange, along with streamlined regulatory interactions and access to additional funding sources.
Analysis · JUSHF · Life Sciences
Jushi Holdings Inc. is seeking shareholder approval to redomicile from British Columbia, Canada, to Nevada, USA. This strategic move aims to align the company's legal structure with its US-based operations, enhance access to US capital markets, and potentially facilitate a future listing on a major US stock exchange if cannabis regulations evolve. The proposal includes a significant restructuring of the authorized share capital from unlimited shares to a fixed 2 billion common shares and 1 billion preferred shares, while ensuring no immediate dilution for existing shareholders. This definitive proxy statement sets the stage for a critical vote on the company's long-term strategic direction and capital structure.
At the time of this filing, JUSHF was trading at $0.52 on OTC in the Life Sciences sector, with a market capitalization of approximately $103.8M. The 52-week trading range was $0.27 to $0.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.